Poster Abstract Session:
256. Transplantation - Prophylaxis and Prediction
Saturday, October 7, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD


Presentations:
Comparison of Posaconazole and Voriconazole Prophylaxis Following Induction Chemotherapy for Acute Myeloid Leukemia
Derek Bremmer, PharmD, BCPS; Monank Patel, PharmD, BCPS, BCOP; Matthew Moffa, DO; Thomas Walsh, MD
Low-dose valganciclovir for CMV prophylaxis in intermediate-risk liver transplant recipients: a single center retrospective study
Salman Khan, MD; Timothy Sullivan, MD; Mohsin Ali, MPhil; Dallas Dunn, MD; Gopi Patel, MD, MS; Shirish Huprikar, MD
Role of secondary prophylaxis with valganciclovir in the prevention of recurrent cytomegalovirus disease in solid organ transplant recipients
Bradley Gardiner, MBBS, FRACP, MS; Jennifer Chow, MD, MS; Lori Lyn Price, MAS, MLA; Natalie Nierenberg, MD, MPH; David Kent, MD; David R Snydman, MD
Use of a Sulfa Desensitization Protocol in Solid Organ Transplant Recipients
Denise Kirsch, MD; Ali Olyaei, PharmD; Joshua Wiegel, PharmD, BCPS; Lynne Strasfeld, MD
Posters
  • 2389_IDWPOSTER.pdf (392.6 kB)
  • Establishing the Optimal Viral Load Threshold for Initiation of Therapy for Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients: A Prospective Derivation Cohort Study Using the International Standardized CMV Quantitative Nucleic Acid Testing
    Zachary Hanna, (DO); Megan Karrick, (DO); Rachna Jayaprakash, MD; William Morgan, (DO); Samaa Lutfi, (DO); Kulothungan Gunasekaran, MD; Ramon Del Busto, MD; George Alangaden, MD, FIDSA; Odaliz Abreu-Lanfranco, MD; Linoj Samuel, PhD., D(ABMM); Mayur Ramesh, MD
    Impact of Choice of Surgical Infection Prophylaxis in Left ventricular Assist Device Infections
    Nana Aburjania, MD; Brennan Ertmer, PharmD; Saira Farid, MD; Melody Berg, PharmD, BCPS AQ-ID; Juhsien JC Nienaber, MD; Vakhtang Tchantchaleishvili, MD; John Stulak, MD; M. Rizwan Sohail, MD
    Revisiting Infectious Complications in Hematopoetic Stem Cell Transplantation Recipients who Receive Total Parenteral Nutrition
    Steven Trifilio, Assistant Professor; Halina Rubin, PharmD; Jessica L Fong, PharmD; Deborah Greenberg, PharmD; Cindy Zhao, BS; Solomiya Grushchak, BS; Jayesh Mehta, MD
    Comparative Effectiveness of Cidofovir Pre-emptive Therapy for Human Adenovirus Infection in Pediatric Hematopoietic Cell Transplant Recipients
    Craig L.K. Boge, MPH; Hans Petersen, MS; Alix E. Seif, MD, MPH; Ana Maria Cardenas, PhD, D(ABMM); Matthew Bryan, PhD; Dale Purdy, BS; Brandon Loudon, CCRP, AS; Adriana E. Kajon, PhD; Brian T. Fisher, DO, MSCE, MPH
    Multi-Center Observational Characterization of Cytomegalovirus Antiviral use in Allogenic Hematopoietic Stem-Cell Transplantation (HCT) Recipients
    William Musick, PharmD; Nancy Vuong, PharmD; Samuel L. Aitken, PharmD; Siyun Liao, PharmD; Dayna McManus, PharmD, BCPS AQ-ID; James Cox, PharmD; Katherine Perez, PharmD, BCPS-AQ ID; Eric Tichy, PharmD; Jeffrey Topal, MD; Stuart Seropian, MD; Larry H. Danziger, Pharm.D., FIDSA; Kevin W. Garey, PharmD, M.S.
    Febrile Neutropenia Syndromes in Children: Should Management Differ for Primary, Persistent, Recurrent or Engraftment Fever?
    Muayad Alali, MD; Michael Z David, MD PhD; Allison Bartlett, MD; Lindsay Petty, MD; Anoop Mayampurath, PhD; Jennifer Pisano, MD
    Impact of a shorter duration of antimicrobial prophylaxis in orthotopic liver transplantation (OLT) patients
    Aiman Bandali, Pharm.D.; Tiffany Bias, PharmD, BCPS, AAHIVP; Dong Heun Lee, MD; Gregory Malat, PharmD, BCPS
    Burden of Cytomegalovirus DNAemia among Pediatric Renal Transplant Patients on Antiviral Prophylaxis: A Hospital-Based Analysis
    Kayur Mehta, MD; Ohoud Al-Yabes, MD; Astrid Petrich, MD; Angela Williams, RN, MS; Diane Hebert, MD; Valerie Langlois, MD, FRCPC; Upton Allen, MD, FIDSA
    Patterns of Linezolid and Daptomycin Use in Leukemia Patients with Neutropenic Fever Presenting to the Emergency Center
    Samuel L. Aitken, PharmD; Deeksha Jandhyala, M.D.; Victor E. Mulanovich, MD; Kayleigh R. Marx, PharmD; Frank P. Tverdek, PharmD; Roy F. Chemaly, MD, MPH, FIDSA, FACP; Kenneth V. I. Rolston, MD; Samuel A. Shelburne, MD, PhD
    The Characteristics of Febrile Neutropenia among Allogeneic Hematopoietic Stem Cell Transplant Recipients on Levofloxacin Prophylaxis.
    Sho Ogura, MD; Muneyoshi Kimura, MD; Hideki Araoka, MD; Mitsuhiro Yuasa, MD; Daisuke Kaji, MD; Kosei Kageyama, MD; Aya Nishida, MD; Shinsuke Takagi, MD; Hisashi Yamamoto, MD; Go Yamamoto, MD; Yuki Asano-Mori, MD; Naoyuki Uchida, MD; Shuichi Taniguchi, MD; Akiko Yoneyama, MD
    Effectiveness of Fluoroquinolone Prophylaxis for High Risk Patients with Neutropenia in Hematopoietic Stem Cell Transplant Recipients in the Era of Rising Gram Negative Bacterial Resistance
    Zachary Hanna, (DO); Rodeo Abrencillo, MD; Rachna Jayaprakash, MD; Ramon Del Busto, MD; Odaliz Abreu-Lanfranco, MD; George Alangaden, MD, FIDSA; Nalini Janakiraman, MD; Mayur Ramesh, MD
    “Immune response to Bordetella pertussis vaccine in candidates and receptors of solid organ transplant”
    Armelle Marveya Perez Cortes Villalobos, MD, MSc; Juan Jose Calva Mercado, MD MSc; Gustavo Pedraza, CHEM; Luis Eduardo Morales Buenrostro, MD, MSc; Guillermo Ruiz-Palacios, MD, FIDSA; Jennifer Cuellar-Rodríguez, MD
    Posters
  • Cartel Armelle jcr.pdf (374.7 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.